New Jersey：飞利浦 CPAP 召回诉讼 | DrugsMonitor.com

飞利浦 CPAP 召回诉讼New Jersey (NJ) 中：与 MDL 相关的练习笔记、提交截止日期背景以及保密的律师审查，而非法律建议。

PE-PUR 泡沫、BiPAP、睡眠呼吸暂停装置、呼吸损伤, New Jersey

Sleep-apnea patients in New Jersey (NJ) who used recalled Philips devices and developed serious lung conditions or cancers may inquire about the Western Pennsylvania MDL. Counsel can discuss device registration, proof of use, and New Jersey-specific filing issues.

Recall background

FDA classified the recall as Class I for many units—the most serious level—citing potential toxic and carcinogenic effects from foam breakdown, especially with ozone cleaning or high heat/humidity storage.

Plaintiffs assert design defect, failure to warn, and negligence; defendants dispute injury causation and exposure levels.

新泽西州 context

协调一致的 MDL 实践塑造了 飞利浦 CPAP 召回诉讼 的共同发现，但 新泽西州 读者通常仍然就 NJ 报关、医疗记录访问和任何并行的国家行动如何符合他们自己的时间顺序提出建议。

西部地区的旅行距离、法院积压案件和当地专家市场各不相同； 新泽西州 客户有时会首先以数字方式合并记录，因为 NJ 围绕 HIPAA 授权的做法可能会减慢纸张提取速度。